Acute Ischemic Stroke Care Quality Improvement
This economic evaluation analyzes retrospective and prospective data in 9 quality measures to determine their value in improving care for patients who have had a stroke.
Related Articles
Fracture Risk Assessment as a Component of Osteoporosis Screening
At first glance, the updated US Preventive Services Task Force (USPSTF) Recommendation Statement on osteoporosis screening1 appears nearly identical to the previous 2018 statement, especially…
USPSTF Recommendation: Screening for Osteoporosis to Prevent Fractures
This 2025 Recommendation Statement from the US Preventive Services Task Force recommends screening for osteoporosis to prevent osteoporotic fractures in women 65 years or older…
Telling your child to finish their plate could fuel obesity crisis
A fifth of four to five-year-olds in England are obese, with parents possibly contributing by giving them portions that are too big
Vaccines for Covid-19: A Personal Reflection
Vaccines for Covid-19: A Personal Reflection by Robert M. Califf, MD
Vaccines for Covid-19: A Personal Reflection
Vaccines for Covid-19: A Personal Reflection by Robert M. Califf, MD
Right ventricular dyssynchrony predicts outcome in pulmonary arterial hypertension when assessed in multiple cardiac magnetic resonance views
Right ventricular (RV) dyssynchrony or post systolic contraction (PSC) causes inefficient pumping and has not been investigated as a prognostic marker in pulmonary arterial hypertension…
Genomic Profiling of Small-Bowel Adenocarcinoma
This cohort study evaluates the genomic profile of patients with small-bowel adenocarcinoma compared with colorectal cancer and gastric carcinoma.
Welcome to the 119th Congress
Now that the 119th Congress has convened in Washington, DC, it’s time to continue our efforts in educating both new and returning lawmakers about our…
Atrial Fibrillation and Retinal Stroke
This cohort study examines whether there is an association between atrial fibrillation and retinal stroke in US adults aged 66 years and older.
Genetic Ancestry–Based Differences in Biomarker-Based Eligibility for Precision Oncology Therapies
This cohort study examines if the approval of precision oncology therapies has benefited patients with cancer from various ancestral backgrounds equally over time.
